• Uniper signs capacity reservation agreement for future SAF supply from Syzygy Plasmonics’ NovaSAF™ platform
• This agreement reflects growing market momentum in biogas to SAF technology and provides the European Union with alternative pathways to achieve SAF Mandate goals
• Agreement brings additional commercial traction to Syzygy’s NovaSAF™ project pipeline
• Uniper’s global low-carbon offtake portfolio to be expanded through participation in an innovative biogas-to-SAF value chain

HOUSTON and DÜSSELDORF, Germany, Oct. 1, 2026 /PRNewswire/ — Uniper has joined a growing list of aviation fuel buyers that have reserved future production capacity from Syzygy Plasmonics’ NovaSAF™ platform, as commercial momentum behind the company’s biogas-to-SAF technology continues to build.

The agreement adds to Uniper’s low carbon portfolio and brings additional commercial traction to Syzygy’s planned NovaSAF™ facilities in Central and South America, as NovaSAF-1 in Uruguay approaches a final investment decision. More importantly, the agreement for Syzygy’s dual-certified pathway helps to enhance the European Union’s ability to meet mandate targets for both bio and RFNBO SAF.

Trevor Best, CEO Syzygy Plasmonics: “Uniper’s decision to reserve NovaSAF™ capacity reflects the commercial traction our platform is attracting at the moment when it is most needed to meet mandate volumes. Agreements like this affirm that the market is moving to meet EU commission targets and companies like Syzygy have the right product, at the right time, with the right volumes.”

Benedikt Messner, SVP New Energies, Uniper: “Uniper is committed to building a diversified portfolio of low-carbon energy solutions that support our customers’ decarbonization goals. Securing access to Syzygy’s innovative technology is another important step in building our position in a market with significant growth potential and complements our recent announcements in advancing our sustainable fuels strategy.”

Bringing certainty to a diversified low carbon supply portfolio

For Uniper, the agreement represents a deliberate step in building a low carbon energy portfolio that includes sustainable aviation fuel. As European aviation faces growing demand under ReFuelEU and CORSIA, securing forward supply from biogas-to-SAF pathways positions Uniper to serve customers in an increasingly dynamic market.

NovaSAF™: a scalable biogas-to-SAF platform

NovaSAF™ is Syzygy Plasmonics’ commercial project platform, converting biogas to sustainable aviation fuel using the company’s proprietary Rigel photocatalytic reactor. Designed for cost competitive production, NovaSAF™ facilities are planned globally. NovaSAF-1 in Uruguay is at final investment decision, a milestone that reflects the strength and readiness of the platform.

About Syzygy Plasmonics
Syzygy Plasmonics is a Houston based technology company developing light driven reactor technology to decarbonize fuel and chemical production. Its proprietary Rigel photocatalytic reactor enables biogas conversion to sustainable aviation fuel at competitive cost and carbon intensity. Learn more at www.plasmonics.tech.

About Uniper
Düsseldorf-based Uniper is a European energy company with global reach. It has about 7,000 employees and plays a key role in ensuring a secure energy supply in Europe, particularly in its core markets of Germany, the United Kingdom, Sweden, and the Netherlands. Uniper’s 18.5 gigawatts of power generating capacity make it a mainstay of reliable power production. Uniper is a leading gas trader and one of Northwestern Europe’s most important LNG importers, and its broad procurement portfolio enhances supply security. Uniper’s investments in renewables, hydrogen, and other low-carbon energy carriers propel the transformation of the energy system.

Uniper provides energy and services to about 1,000 municipalities and industrial companies in its home market, Germany. Uniper is also Germany’s largest operator of gas storage facilities and hydropower plants.

This press release may contain forward-looking statements based on current assumptions and forecasts made by Uniper SE management and other information currently available to Uniper. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. Uniper SE does not intend, and does not assume any liability whatsoever, to update these forward-looking statements or to modify them to conform with future events or developments.

View original content to download multimedia:https://www.prnewswire.com/news-releases/syzygy-plasmonics-signs-capacity-reservation-agreement-with-uniper-for-planned-facilities-in-latin-america-302895299.html

SOURCE Syzygy Plasmonics